Literature DB >> 34559487

Langerhans cell histiocytosis: Case report and literature review

Miguel Ángel Medina1, Wendy Meyer2, Carolina Echeverri3, Natalia Builes4.   

Abstract

Histiocytosis comprises a heterogeneous group of inflammatory diseases whose main cellular components are dendritic cells and macrophages. The inflammatory infiltrate can affect the skin and other organs and the clinical outcome varies from mild to fatal depending on the involved cell subset and multisystemic compromise. Delay in diagnosis may occur due to its non-specific presentation and to a low suspicion on the part of the clinician. We report the case of an infant who despite multiple consultations with nonspecific but characteristic symptoms of the disease was only finally diagnosed thanks to histopathological findings.

Entities:  

Keywords:  Histiocytosis; Langerhans-cell; pediatrics; conjunctivitis; dermatitis; seborrheic

Mesh:

Year:  2021        PMID: 34559487      PMCID: PMC8519595          DOI: 10.7705/biomedica.5430

Source DB:  PubMed          Journal:  Biomedica        ISSN: 0120-4157            Impact factor:   0.935


  24 in total

Review 1.  Central nervous system disease in Langerhans cell histiocytosis.

Authors:  Nicole Grois; Bernhard Fahrner; Robert J Arceci; Jan-Inge Henter; Kenneth McClain; Hans Lassmann; Vasanta Nanduri; Helmut Prosch; Daniela Prayer
Journal:  J Pediatr       Date:  2010-06       Impact factor: 4.406

2.  How I treat Langerhans cell histiocytosis.

Authors:  Carl E Allen; Stephan Ladisch; Kenneth L McClain
Journal:  Blood       Date:  2015-03-31       Impact factor: 22.113

3.  Pediatric Langerhans cell histiocytosis: the impact of mutational profile on clinical progression and late sequelae.

Authors:  D Nann; P Schneckenburger; J Steinhilber; G Metzler; R Beschorner; C P Schwarze; P Lang; R Handgretinger; Falko Fend; M Ebinger; I Bonzheim
Journal:  Ann Hematol       Date:  2019-03-28       Impact factor: 3.673

4.  Risk factors for diabetes insipidus in langerhans cell histiocytosis.

Authors:  N Grois; U Pötschger; H Prosch; M Minkov; M Arico; J Braier; J-I Henter; G Janka-Schaub; S Ladisch; J Ritter; M Steiner; E Unger; H Gadner
Journal:  Pediatr Blood Cancer       Date:  2006-02       Impact factor: 3.167

5.  An exploratory epidemiological study of Langerhans cell histiocytosis.

Authors:  Rajkumar Venkatramani; Shira Rosenberg; Gitanjali Indramohan; Michael Jeng; Rima Jubran
Journal:  Pediatr Blood Cancer       Date:  2012-03-20       Impact factor: 3.167

Review 6.  Pediatric Langerhans cell histiocytosis: state of the science and future directions.

Authors:  Nirav H Thacker; Oussama Abla
Journal:  Clin Adv Hematol Oncol       Date:  2019-02

Review 7.  Multisystem Langerhans cell histiocytosis in children: current treatment and future directions.

Authors:  Milen Minkov
Journal:  Paediatr Drugs       Date:  2011-04-01       Impact factor: 3.022

Review 8.  Childhood Langerhans cell histiocytosis: a disease with many faces.

Authors:  Alexander K C Leung; Joseph M Lam; Kin Fon Leong
Journal:  World J Pediatr       Date:  2019-08-28       Impact factor: 2.764

9.  Endocrine involvement in pediatric-onset Langerhans' cell histiocytosis: a population-based study.

Authors:  Jean Donadieu; Maria-Alejandra Rolon; Caroline Thomas; Laurence Brugieres; Dominique Plantaz; Jean François Emile; Didier Frappaz; Michel David; Raja Brauner; Thierry Genereau; Dominique Debray; Sylvie Cabrol; Marie-Anne Barthez; Khé Hoang-Xuan; Michel Polak
Journal:  J Pediatr       Date:  2004-03       Impact factor: 4.406

10.  Langerhans cell histiocytosis of the jaw, a mimicker of osteomyelitis on CT and MR images: A retrospective analysis.

Authors:  Jo-Eun Kim; Won-Jin Yi; Min-Suk Heo; Sam-Sun Lee; Soon-Chul Choi; Kyung-Hoe Huh
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.